Clinical Trial Update: Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Double-blinded Randomized Controlled Clinical Trial [Phase 1]

View source ↗

Summary

Phase 1 double-blind randomized trial assessing the safety and potential efficacy of Wharton’s jelly–derived mesenchymal stem cell exosomes for diabetic foot ul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes (exosome therapy derived from Wharton’s jelly mesenchymal stem cells)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Diabetic Foot Ulcer (DFU), Exosomes | Phase 1 | Status: COMPLETED